Skip to main content
      What are effects of TNFi on Lipids in AxSpA?
      Ab#0531 #ACR23 @RheumNow
      320 pts w AS - retrosp cohort, first-line TNFi, n

      Eric Dein

      1 year ago
      What are effects of TNFi on Lipids in AxSpA? Ab#0531 #ACR23 @RheumNow 320 pts w AS - retrosp cohort, first-line TNFi, not on lipid Rx Chol and TG increase in 1st 3 mos of treatment. LDL & HDL: no signif change Inflam markers/Lipids correlated - suspect due to anti-inflamm effect https://t.co/qT5qUEOEvO
      Is exercise safe in PsO/PsA? Ab0497 #ACR23
      US of entheses before & after 60 min of badminton 🏸
      7 PsA pts, 9 PsO p

      Eric Dein

      1 year ago
      Is exercise safe in PsO/PsA? Ab0497 #ACR23 US of entheses before & after 60 min of badminton 🏸 7 PsA pts, 9 PsO pts, 196 US scans acquired. No signif change in VAS pain/tender entheses 4 pts w grade 1 doppler at 6 entheses, butnon-tender 1 pt w active PsA had worsening @RheumNow https://t.co/nsi9b6px0X
      Translational implication/application of the #APOL1 story :
      Risk stratification, novel treatments, impact of tissue sus

      TheDaoIndex KDAO2011

      1 year ago
      Translational implication/application of the #APOL1 story : Risk stratification, novel treatments, impact of tissue susceptibility to damage #ACR23 @RheumNow #DuboisLecture #SLE @ashira_md https://t.co/k23vFjeDeG
      Ab#498 Does DMARD for PsO and PsA decrease MACE?
      #ACR23 @RheumNow
      Retrospective database Israeli study.
      PsO, PsA on MTX

      Eric Dein

      1 year ago
      Ab#498 Does DMARD for PsO and PsA decrease MACE? #ACR23 @RheumNow Retrospective database Israeli study. PsO, PsA on MTX or bDMARD: lower MACE compared to health matched controled (HR 0.45-0.68, p<0.001) Pts on topical Rx had marginally Increased MACE (HR 1.14, p <0.001) https://t.co/0uRgjzYbFp
      BKZ tx resulted in sustained improvements in pt‑reported pain and fatigue from Wk 16 - 52 in bDMARD-naïve and TNFi-IR

      Dr. Rachel Tate

      1 year ago
      BKZ tx resulted in sustained improvements in pt‑reported pain and fatigue from Wk 16 - 52 in bDMARD-naïve and TNFi-IR pts w/ active PsA, w/ clinically meaningful improvements observed in >50% of pts in BE-OPTIMAL & BE-COMPLETE #ACR23 Abs 0527 https://t.co/AQKYUubKLl @rheumnow https://t.co/WsXlhENzL1
      Abs#0501 @RheumNow #ACR23
      Uveitis in SpA, from Greece
      AxSpA: 11.7% Uveitis. RF: HLA-B27 (OR 4.15), periperhal arthritis

      Eric Dein

      1 year ago
      Abs#0501 @RheumNow #ACR23 Uveitis in SpA, from Greece AxSpA: 11.7% Uveitis. RF: HLA-B27 (OR 4.15), periperhal arthritis (OR 3.05) PsA: 2.7% Uveitis. Ass w/ SpA FHx, Axial dis at dx, disease duration Permanent vision loss in 16% AxSpA, 30% PsA pts, all with recurrent uveitis
      EISER study: Undiagnosed IBD in SpA
      Abs#0495 #ACR23 @RheumNow
      559 pts, 47% PsA/53% SpA (80% r-AxSpA)
      Higher mean fecal c

      Eric Dein

      1 year ago
      EISER study: Undiagnosed IBD in SpA Abs#0495 #ACR23 @RheumNow 559 pts, 47% PsA/53% SpA (80% r-AxSpA) Higher mean fecal calprotectin in r-AxSpA (395 vs 305 nrAxSpA/PsA) 14.6% IBD symptoms, 23 patients (4.4% were dx w IBD) Fecal calprotectin & history can uncover IBD #ACRBest
      #ACR23 Please find my preview article on selected #SLE abstracts to be presented at year’s conference - towards Glucoc

      Md Yuzaiful Md Yusof

      1 year ago
      #ACR23 Please find my preview article on selected #SLE abstracts to be presented at year’s conference - towards Glucocorticoid-Free zone in lupus @RheumNow https://t.co/1kM7LWc64V https://t.co/WK9X7UpsNi
      High hs-CRP predicts PsO -> PsA?
      Abs#0484 #ACR23 @RheumNow
      589 PsO pts wo PsA, followed mean 7.5 years
      57 pts develo

      Eric Dein

      1 year ago
      High hs-CRP predicts PsO -> PsA? Abs#0484 #ACR23 @RheumNow 589 PsO pts wo PsA, followed mean 7.5 years 57 pts developed PsA (1.2 events/yr) Higher levels of b/l hs-CRP seen w: arthrlalgia, obesity, females Higher hs-CRP ass. w/ PsA - p=0.002, but HR only 1.03 (CI 1.01-1.05)
      Long term results of the MAINRITSAN study (Maintenance Remission w/ RTX in Systemic AAV) showed fixed-schedule RTX sup

      Dr. John Cush RheumNow

      1 year ago
      Long term results of the MAINRITSAN study (Maintenance Remission w/ RTX in Systemic AAV) showed fixed-schedule RTX superior to AZA in preventing major relapses at 84mos (HR 0.38), but tailored-RTX assoc w/ incr risk of major relapse (HR 2.92) https://t.co/vucBYeM1P5 https://t.co/YqdqZWFhfd
      In young patients who have a spinal MRI, lesions are reported in most patients, and similar in males:females. SIJ MRI fi

      Dr. Antoni Chan

      1 year ago
      In young patients who have a spinal MRI, lesions are reported in most patients, and similar in males:females. SIJ MRI findings are reported in one out of three patients, being more frequently in males @DiegoBenavent Abst #160 #ACR23 @RheumNow https://t.co/aF9WnP7jpY https://t.co/E9UuZ0sWZm
      #Benefits of #hudroxychloroquine - reduced lipids, clots, CV events, infection AND now improved #fatty #liver #NAFLD….

      Janet Pope

      1 year ago
      #Benefits of #hudroxychloroquine - reduced lipids, clots, CV events, infection AND now improved #fatty #liver #NAFLD….@RheumNow #ACR23 @ACRheum https://t.co/Y43JETY6F3
      Sarilumab for relapsing of PMR. Any thing to to taper off prednisone quickly.

      #ACR23 , year in review.

      Lost of goo

      Nouf Al hemmadi

      1 year ago
      Sarilumab for relapsing of PMR. Any thing to to taper off prednisone quickly. #ACR23 , year in review. Lost of good studies and smart discussions @RheumNow at Make rheum for PMR month. https://t.co/VyRP8ls3OC
      Thank you @synovialjoints @RheumNow for highlighting our work

      #ACR23 #ACRambassador
      @ACRheum
      @ArLARheumatolog
      #ARCH_A

      Nelly ZIADE 🍀 Nellziade

      1 year ago
      Thank you @synovialjoints @RheumNow for highlighting our work #ACR23 #ACRambassador @ACRheum @ArLARheumatolog #ARCH_ArLAR https://t.co/rphaODphD1
      If successful you may need how to pronounce these emerging therapeutics in #inflammatory #arthritis @RheumNow #ACR23 @AC

      Janet Pope

      1 year ago
      If successful you may need how to pronounce these emerging therapeutics in #inflammatory #arthritis @RheumNow #ACR23 @ACRheum https://t.co/aOogwQCsCM